Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
Tóm tắt
Exposures to perfluoroalkyl substances (PFAS) have shown positive associations with serum lipids in previous studies. While many studies on lipids investigated associations with perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), there are only a few studies regarding other PFAS, such as perfluorohexane sulfonic acid (PFHxS). The purpose of the current study is to investigate if associations with serum lipids were present, not only for serum PFOS and PFOA, but also for PFHxS, and if the associations with PFAS remained also in a comparison based only on residency in areas with contrasting exposure to PFAS. 1945 adults aged 20–60 were included from Ronneby, Sweden, a municipality where one out of two waterworks had been heavily contaminated from aqueous fire-fighting foams, and from a nearby control area. The exposure was categorized based on either been living in areas with contrasting PFAS exposure or based on the actual serum PFAS measurements. Regression analyses of serum lipids were fitted against serum PFAS levels, percentile groups, smooth splines and between exposed and reference areas, adjusting for age, sex and BMI. Drinking water contamination caused high serum levels of PFOS (median 157 ng/ml) and PFHxS (median 136 ng/ml) and PFOA (median 8.6 ng/ml). These serum PFAS levels in the exposed groups were 5 to 100-fold higher than in the controls. In this population with mixed PFAS exposure, predominantly PFOS and PFHxS, PFAS exposure were positively associated with serum lipids. This was observed both when quantifying exposure as contrast between exposed and controls, and in terms of serum PFAS. Due to high correlations between each PFAS, we cannot separate them. In conclusion, the present study provides further evidence of a causal association between PFAS and serum lipids, especially for PFHxS.
Tài liệu tham khảo
Vestergren R, Cousins IT. Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol. 2009;43:5565–75. PMID: 19731646. https://doi.org/10.1021/es900228k.
Thalheimer AH, McConney LB, Kalinovich IK, Pigott, AV, Franz JD, Holbert, HT, Mericas D, Puchacz ZJ. 2017. Use and potential impacts of AFFF containing PFASs at airports. Washington, D.C. Transportation Research Board.
Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, et al. Pre- and postnatal exposure to perfluorinated compounds (PFCS). Environ Sci Technol. 2010;44:7123–9. PMID: 20722423. https://doi.org/10.1021/es101184f.
Haug LS, Huber S, Becher G, Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds--comparing exposure estimates with biomarkers of exposure. Environ Int. 2011;37:687–93. PMID: 21334069. https://doi.org/10.1016/j.envint.2011.01.011.
Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol. 2009;170:1268–78. PMID: 19846564. https://doi.org/10.1093/aje/kwp279.
Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75:46–51. PMID: 29133598. https://doi.org/10.1136/oemed-2017-104651.
EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), Knutsen HK, Alexander J, Barregard L, Bignami M, Brüschweiler B, Ceccatelli S, et al. Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA J. 2018;16(12):5194, 284. https://doi.org/10.2903/j.efsa.2018.5194.
Fisher M, Arbuckle TE, Wade M, Haines DA. Do perfluoroalkyl substances affect metabolic function and plasma lipids? Analysis of the 2007–2009, canadian health measures survey (CHMS) cycle 1 (vol 121, pg 95, 2013). Environ Res. 2013;126:221. PMID: 23266098. https://doi.org/10.1016/j.envres.2012.11.006.
Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. Population. Environ Health Perspect. 2010;118:197–202. PMID: 20123614. https://doi.org/10.1289/ehp.0901165.
Starling AP, Engel SM, Whitworth KW, Richardson DB, Stuebe AM, Daniels JL, et al. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the norwegian mother and child cohort study. Environ Int. 2014;62:104–12. PMID: 24557813. https://doi.org/10.1093/aje/kwt432.
Zeng XW, Qian ZM, Emo B, Vaughn M, Bao J, Qin XD, et al. Association of polyfluoroalkyl chemical exposure with serum lipids in children. Sci Total Environ. 2015;512:364–70. PMID: 25638651. https://doi.org/10.1016/j.scitotenv.2015.01.042.
Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, et al. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiology. 2013;24:569–76. PMID: 23685825. https://doi.org/10.1097/EDE.0b013e31829443ee.
Winquist A, Steenland K. Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect. 2014;122:1299–305; PMID: 25260175. https://doi.org/10.1289/ehp.1307943.
Lin PID, Cardenas A, Hauser R, Gold DR, Kleinman KP, Hivert MF, et al. Per-and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults—longitudinal analysis of the diabetes prevention program outcomes study. Environ Int. 2019;129:343–53; PMID: 31150976. https://doi.org/10.1016/j.envint.2019.05.027.
EFSA CONTAM panel (EFSA panel on contaminants in the food chain), 2018b, Minutes of the expert meeting on perfluooroctane sulfonic acid and perfluorooctanoic acid in food assessment.
Salihović S, Dickens AM, Schoultz I, Fart F, Sinisalu L, Lindeman T, et al. Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem. 2019. https://doi.org/10.1007/s00216-019-02263-6.
Lindh CH, Rylander L, Toft G, Axmon A, Rignell-Hydbom A, Giwercman A, et al. Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations. Chemosphere. 2012;(11):88, 1269–1275. PMID: 22494529. https://doi.org/10.1016/j.chemosphere.2012.03.049.
Wood SN. 2017. Generalized additive models: an introduction with R. Chapman and Hall/CRC.
Eriksen KT, Raaschou-Nielsen O, McLaughlin JK, Lipworth L, Tjonneland A, Overvad K, et al. Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged danish population. PLoS One. 2013;8:e56969. PMID: 23441227. https://doi.org/10.1371/journal.pone.0056969.
Skuladottir M, Ramel A, Rytter D, Haug LS, Sabaredzovic A, Bech BH, et al. Examining confounding by diet in the association between perfluoroalkyl acids and serum cholesterol in pregnancy. Environ Res. 2015;143:33–8. PMID: 26432473. https://doi.org/10.1016/j.envres.2015.09.001.
Fletcher T, Galloway TS, Melzer D, Holcroft P, Cipelli R, Pilling LC, et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ Int. 2013;57:2–10. PMID: 23624243. https://doi.org/10.1016/j.envint.2013.03.008.
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–39. PMID: 18061058. https://doi.org/10.1016/S0140-6736(07)61778-4.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47. https://doi.org/10.1161/01.CIR.97.18.1837.
Château-Degat M-L, Pereg D, Dallaire R, Ayotte P, Dery S, Dewailly É. Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (northern quebec). Environ Res. 2010;110:710–7. PMID: 20696425. https://doi.org/10.1016/j.envres.2010.07.003.
Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: Results from the C8 health project. Arch Pediatr Adolesc Med. 2010;164:860–9. PMID: 20819969. https://doi.org/10.1001/archpediatrics.2010.163.